Arcas is a precision oncology therapeutics platform built around state-of-the-art AI technology. We are using a multi-level deep learning approach to integrate clinical, genomic, and pharmacological data.

Arcas allows us to leverage complex molecular signatures and make use of pre-clinical drug screening data in a way that is predictive of clinical performance. This technology offers unmatched translatability of pre-clinical drug screening information. In a similar vein, Arcas technology enables more precise biomarkers for future clinical trials which will turn into more precise companion diagnostics.

Arcas precision oncology platform is financially and organizationally supported by the Berlin Institute of Health and Max Delbrück Center for Molecular Medicine.